Senti Biosciences, Inc. (Nasdaq: SNTI) ("Senti Bio” or the "Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit ...
In a recent interview with Fierce Biotech's Chris Hayden, Fortrea's Chief Technology and Data Officer Alaric Jackson ...
| Avoid common pitfalls in EU orphan drug market access—learn how local expertise can help navigate pricing, reimbursement, ...
In a highly anticipated hearing, Judge Angel Kelley at times appeared skeptical of the government’s arguments.
New rules from Brussels aim to streamline biopesticide and biocontrol approvals, addressing the outdated process and helping Europe stay competitive in the global market. #EuropeNews ...
In her second year of studies at Republic Polytechnic, biotechnology student Joanne Chew decided to apply for a scholarship ...
Understanding biosimilars, biologics, and the challenges surrounding their regulation and pricing in the pharmaceutical ...
To McIntosh, the most surprising bankruptcy of 2024 was Eiger BioPharmaceuticals, a metabolic disease biotech that was ...
The field of agricultural science is increasingly focusing on the application of green technologies to combat plant stress ...
In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...
Speaking about IIT Guwahati's commitment to developing cutting-edge biotechnologies, Prof. Devendra Jalihal, Director, IIT Guwahati, said, "IIT Guwahati is committed to advancing research that creates ...
USDA Animal and Plant Health Inspection Service (APHIS) announced on January 23, 2025, that it is reinstating its legacy ...